0001209191-23-014292.txt : 20230301 0001209191-23-014292.hdr.sgml : 20230301 20230301183226 ACCESSION NUMBER: 0001209191-23-014292 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230209 FILED AS OF DATE: 20230301 DATE AS OF CHANGE: 20230301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WALDRON RICHARD A CENTRAL INDEX KEY: 0001226961 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39787 FILM NUMBER: 23695601 MAIL ADDRESS: STREET 1: 901 MARINERS ISLAND BLVD STE.205 CITY: SAN MATEO STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioAtla, Inc. CENTRAL INDEX KEY: 0001826892 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851922320 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11085 TORREYANA ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-558-0708 MAIL ADDRESS: STREET 1: 11085 TORREYANA ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-09 0 0001826892 BioAtla, Inc. BCAB 0001226961 WALDRON RICHARD A C/O BIOATLA, INC. 11085 TORREYANA ROAD SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Common Stock 2023-02-28 4 F 0 970 2.98 D 129660 D Employee Stock Option (right to buy) 3.95 2023-02-09 4 A 0 210000 0.00 A 2033-02-09 Common Stock 210000 210000 D This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. The option vests over a period of four years, with 25% of the shares underlying the option vesting on the first anniversary of the date of grant, and the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued service to the company through the applicable vesting dates. /s/ Christian Vasquez, as Attorney-in-Fact for Richard A. Waldron 2023-03-01